Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1950 2
1951 1
1953 1
1954 2
1955 1
1957 1
1958 1
1959 1
1960 1
1961 1
1962 3
1963 1
1965 1
1966 1
1967 1
1970 1
1971 1
1972 9
1973 1
1974 1
1975 1
1977 2
1982 2
1985 2
1986 67
1987 392
1988 631
1989 1057
1990 1109
1991 1214
1992 1140
1993 1113
1994 1175
1995 1281
1996 1142
1997 956
1998 865
1999 820
2000 872
2001 928
2002 1010
2003 1127
2004 1245
2005 1301
2006 1545
2007 1531
2008 1545
2009 1595
2010 1742
2011 2031
2012 2137
2013 2307
2014 2421
2015 2688
2016 2428
2017 2232
2018 2126
2019 975
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

42,600 results
Results by year
Filters applied: . Clear all
Page 1
Enteral nutritional therapy for induction of remission in Crohn's disease.
Narula N, et al. Cochrane Database Syst Rev 2018 - Review. PMID 29607496 Free PMC article.
BACKGROUND: Corticosteroids are often preferred over enteral nutrition (EN) as induction therapy for Crohn's disease (CD). Prior meta-analyses suggest that corticosteroids are superior to EN for induction of remission in CD. ...Very low quality evidence also suggests that EN may be more effective than steroids for induction of remission in children with active CD. ...
BACKGROUND: Corticosteroids are often preferred over enteral nutrition (EN) as induction therapy for Crohn's disease (CD). Prior meta …
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Peyrin-Biroulet L, et al. Am J Gastroenterol 2015 - Review. PMID 26303131
The agreed target for UC was clinical/patient-reported outcome (PRO) remission (defined as resolution of rectal bleeding and diarrhea/altered bowel habit) and endoscopic remission (defined as a Mayo endoscopic subscore of 0-1). Histological remission was considered as an adjunctive goal. Clinical/PRO remission was also agreed upon as a target for CD and defined as resolution of abdominal pain and diarrhea/altered bowel habit; and endoscopic remission, defined as resolution of ulceration at ileocolonoscopy, or resolution of findings of inflammation on cross-sectional imaging in patients who cannot be adequately assessed with ileocolonoscopy. ...
The agreed target for UC was clinical/patient-reported outcome (PRO) remission (defined as resolution of rectal bleeding and diarrhea …
Dietary and nutritional approaches for prevention and management of type 2 diabetes
Forouhi NG, et al. BMJ 2018 - Review. PMID 29898883 Free PMC article.
Common ground on dietary approaches for the prevention, management, and potential remission of type 2 diabetes can be found, argue Nita G Forouhi and colleagues...
Common ground on dietary approaches for the prevention, management, and potential remission of type 2 diabetes can be found, argue Ni …
Certolizumab pegol for induction of remission in Crohn's disease.
Yamazaki H, et al. Cochrane Database Syst Rev 2019. PMID 31476018 Free PMC article.
OBJECTIVES: The primary objectives were to evaluate the efficacy and safety of CZP for the induction of remission in CD. SEARCH METHODS: We searched MEDLINE, Embase, CENTRAL, the Cochrane IBD group specialized register, trials registers and other sources from inception to 28 January 2019. ...AUTHORS' CONCLUSIONS: Moderate certainty evidence suggests that CZP is effective for induction of clinical remission and clinical response in participants with active CD patients. ...
OBJECTIVES: The primary objectives were to evaluate the efficacy and safety of CZP for the induction of remission in CD. SEARC …
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
Mosli MH, et al. Inflamm Bowel Dis 2015 - Review. PMID 25844963
BACKGROUND: We performed a systematic review to evaluate the efficacy and safety of vedolizumab for induction and maintenance of remission in ulcerative colitis. ...Pooled analyses indicated that vedolizumab was significantly superior to placebo for induction of remission (RR = 0.86, 95% CI, 0.80-0.91), clinical response (RR = 0.82, 95% CI, 0.75-0.91), endoscopic remission (RR = 0.82, 95% CI, 0.75-0.91), and for achieving remission at 52 weeks in week 6 responders (RR = 2.73, 95% CI, 1.78-4.18). ...
BACKGROUND: We performed a systematic review to evaluate the efficacy and safety of vedolizumab for induction and maintenance of r
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven RF, et al. Ann Rheum Dis 2014. PMID 24739325 Free article.
Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of the recommendations were variable but agreement was >0.9 in each case. ...
Prominent features of these recommendations are targeting remission, preventing damage and improving quality of life. LoE and GoR of …
Molecular remission as a therapeutic objective in acute promyelocytic leukemia.
Cicconi L, et al. Leukemia 2018 - Review. PMID 30026570
The results consistently showed that molecular remission (defined as negativization of the PCR test for PML/RARA) correlates with a significantly decreased risk of relapse, whereas persistence of PCR positivity for PML/RARA after consolidation or conversion from negative to positive during follow-up is strongly associated with hematologic relapse. ...Finally, several expert panels have recommended that molecular remission should be considered a therapeutic objective in APL, and molecular response has been adopted as a study endpoint in modern clinical trials....
The results consistently showed that molecular remission (defined as negativization of the PCR test for PML/RARA) correlates with a s …
Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Levine A, et al. Gastroenterology 2019 - Clinical Trial. PMID 31170412
Secondary endpoints were intention to treat (ITT) remission at week 6 (pediatric CD activity index score below 10) and corticosteroid-free ITT sustained remission at week 12. ...Both diets were effective in inducing remission by week 6. The combination CDED plus PEN induced sustained remission in a significantly higher proportion of patients than EEN, and produced changes in the fecal microbiome associated with remission. ...
Secondary endpoints were intention to treat (ITT) remission at week 6 (pediatric CD activity index score below 10) and corticosteroid …
Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis
Papadimitropoulou K, et al. Curr Med Res Opin 2017 - Review. PMID 28035869
A considerable number of patients fail to achieve full symptom remission despite adequate treatment and are considered treatment resistant (TRD). ...CONCLUSIONS: This analysis revealed scarcity of long-term data on sustained remission that would allow a comparative long-term efficacy assessment. ...
A considerable number of patients fail to achieve full symptom remission despite adequate treatment and are considered treatment resi …
42,600 results
Jump to page
Feedback